Preview

Problems of Endocrinology

Advanced search

Effect of amiodarone on thyroid structure and function

https://doi.org/10.14341/probl200854317-21

Abstract

Amiodarone is an effective iodine-rich antiarrhythmic agent that is able to cause thyroid dysfunctions that may substantially worsen health and may be life-threatening. The structure and function of the thyroid was evaluated in 232 patients living in Saint Petersburg who had been receiving amiodarone long (0.6-20 years). During long amiodarone therapy, there were no significant thyroid structural changes; 187 (80%) of the 232 patients had euthyroidism. Thyroid dysfunctions were detected in 45 (20%) patients; amiodarone-induced hypothyroidism (AlH) and amiodarone-induced thyrotoxisis (AIT) were present in 20 (9%) and 25 (119c), respectively. Before amiodarone use, the presence of thyroid peroxidase antibodies significantly increased the risk of AlH (relative risk (RR) 10.0; 95 CI, 8.0-12.0). That of diffuse goiter significantly increased the risk of thyrotoxicosis (RR 5.7; 95% Cl, 4.1-5.9). The serum concentration of thyroid-stimulating hormone receptor antibodies, which had been measured in 23 of the 25 patients with AlT, was used for the differential diagnosis of types I and 2 AIT. As a result, 13 and 10 patients were found to have types 1 and 2 AlT, respectively. The results of other differential diagnostic tests were compared in the groups of patients with types 1 and 2 AlT. Thyroid ultrasonography revealed goiter more frequently in patients with type 1 AlT (10 (779c) of the 13 patients) than in those with type 2 AIT(1 (10%) of the 10 patients; p = 0.01). Color Doppler mapping showed normal or increased thyroid blood flow in all the patients with type 1 AIT and drastically decreased thyroid blood flow in patients with type 2 AIT. In the latter, the serum concentration of free T4 [43.8±3.4 (23.8-62.8)/ pmol/l and the free T/free T, ratio [8.3±0.6 (5.7-12.3) pmol/t were significantly greater than those in patients with type 1AlT[3I.3± 1.3 (25.1- 40.2) and 5.2+0.4 (3.1- 7.7) pmol/l, respectively (p < 0.05). The h ighest sensitivity and specificity in the differential diagnosis of types 1 and 2 AIT were shown by thyroid ultrasonography (SO and 909c), color Doppler mapping (99 and 99%), as well as free T/free T3 ratio (86 and 80%), respectively.

About the Authors

Ye. N. Grineva

Pavlov St. Petersburg State Medical University


Russian Federation


S. V. Dora

Pavlov St. Petersburg State Medical University


Russian Federation


T. V. Malakhova

Pavlov St. Petersburg State Medical University


Russian Federation


Z. L. Malakhova

Pavlov St. Petersburg State Medical University


Russian Federation


References

1. Волкова А. Р., Гринева Е. Н., Цой У. А. // Актуальные проблемы заболеваний щитовидной железы: Материалы 1-й Всероссийской науч.-практ. конф. - М., 2000. - С. 39.

2. Мельниченко Г. А., Свириденко Н. Ю., Молашенко II. В. // Тер. арх. - 2003. - № 8. - С. 92-96.

3. Bartalena L., Grasso L.. Brogioni S. // J. Clin. Endocrinol. Metab. - 1994. - Vol. 78. - P. 423-427.

4. Bartalena L., Brogioni S., Grasso L. et. al. // J. Clin. Endocrinol. Metab. - 1996. - Vol. 81, N 8. - P. 2930-2933.

5. Bogazzi F, Bartalena L., Brogioni S. et. al.// Thyroid. - 1997. -Vol. 7. - P. 541-545.

6. Bogazzi F., Bartalena L., Gasperi M. // Thyroid. - 2001. - Vol. 111, N5.-P. 511-517.

7. Bogazzi F, Raggi F., Ultimieri F. et al. // J. Endocrinol. Invest. -2006. - Vol. 29, N 1. - P. 61-66.

8. Daniels G. H. // J. Clin. Endocrinol. Metab. - 2001. - Vol. 86, N 1. - P. 3-8.

9. Eaton S. E. M., Euinton H. A., Newman С. M. // Clin. Endocrinol. (Oxford). - 2002. - Vol. 56, N 1. - P. 33-38.

10. Komatsu Т., Tachibana H., Sato Y. // Circ. J. - 2007. - Vol. 71, N 1. - P. 46-51.

11. Larsen P. R, Kronenberg H. M., Melmed S, Polonsky K. S. // Williams Textbook of Endocrinology. - Philadelphia, 2003. - P. 405-407.

12. Leung P. M. // Int. J. Clin. Pract. - 2002. - Vol. 56, N 1. -P. 44-46.

13. Martino E., Bartalena L., Brogioni S., Braverman L. E. // Endocr. Rev. - 2001. - Vol. 22, N 2. - P. 240-254.

14. Martino E., Aghini-Lombardi F, Mariotti S. et al. // Clin. Endocrinol. (Oxford). - 1987. - Vol. 26, N 2. - P. 227-237.

15. Pelosi F. Jr., Morady F. // Med. Clin. N. Am. - 2001. -Vol. 85, N 2. - P. 225-244.

16. Trip M. D., Wiersinga W., Plomp T. A. // Am. J. Med. - 1991. - Vol. 91, N 5. - P. 507-511.

17. Vardas P. E., Kochiadakis G. E., Igoumenidis N. E. et al. // Chest. - 2000. - Vol. 117, N 6. - P. 1538-1545.

18. Yanacisawa Т., Sato K., Kato Y. // Endocr. J. - Vol. 52, N 1. - P. 29-36.


Review

For citations:


Grineva Ye.N., Dora S.V., Malakhova T.V., Malakhova Z.L. Effect of amiodarone on thyroid structure and function. Problems of Endocrinology. 2008;54(3):17-21. (In Russ.) https://doi.org/10.14341/probl200854317-21

Views: 6970


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)